A detailed history of Ifrah Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ifrah Financial Services, Inc. holds 1,468 shares of AMGN stock, worth $463,888. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,468
Previous 1,579 7.03%
Holding current value
$463,888
Previous $448,000 2.23%
% of portfolio
0.13%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $29,165 - $35,443
-111 Reduced 7.03%
1,468 $458,000
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $6,721 - $8,114
-25 Reduced 1.56%
1,579 $448,000
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $28,127 - $31,730
-110 Reduced 6.42%
1,604 $461,000
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $2,842 - $3,528
-13 Reduced 0.75%
1,714 $460,000
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $4,928 - $5,827
-23 Reduced 1.31%
1,727 $383,000
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $55,995 - $68,249
-248 Reduced 12.41%
1,750 $423,000
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $13,741 - $17,460
-60 Reduced 2.92%
1,998 $524,000
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $673 - $759
-3 Reduced 0.15%
2,058 $464,000
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $4,844 - $5,391
-21 Reduced 1.01%
2,061 $501,000
Q1 2022

May 03, 2022

BUY
$219.27 - $242.57 $63,588 - $70,345
290 Added 16.18%
2,082 $504,000
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $397 - $455
2 Added 0.11%
1,792 $403,000
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $636 - $746
-3 Reduced 0.17%
1,790 $381,000
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $15,182 - $16,844
-65 Reduced 3.5%
1,793 $437,000
Q1 2021

Apr 30, 2021

SELL
$221.91 - $258.6 $18,418 - $21,463
-83 Reduced 4.28%
1,858 $462,000
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $7,789 - $9,276
-36 Reduced 1.82%
1,941 $446,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $7,274 - $8,089
-31 Reduced 1.54%
1,977 $502,000
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $16,418 - $20,147
-83 Reduced 3.97%
2,008 $474,000
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $364 - $483
2 Added 0.1%
2,091 $424,000
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $5,865 - $7,539
-31 Reduced 1.46%
2,089 $504,000
Q3 2019

Nov 04, 2019

SELL
$174.11 - $208.62 $8,879 - $10,639
-51 Reduced 2.35%
2,120 $410,000
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $7,668 - $8,988
-46 Reduced 2.07%
2,171 $400,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $5,606 - $6,320
-31 Reduced 1.38%
2,217 $421,000
Q4 2018

May 13, 2019

SELL
$178.4 - $208.25 $14,093 - $16,451
-79 Reduced 3.39%
2,248 $438,000
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $17,787 - $20,053
-96 Reduced 3.96%
2,327 $482,000
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $1,494 - $1,678
-9 Reduced 0.37%
2,423 $447,000
Q1 2018

May 03, 2018

SELL
$169.43 - $198.0 $2,710 - $3,168
-16 Reduced 0.65%
2,432 $415,000
Q4 2017

Feb 01, 2018

SELL
$168.79 - $188.59 $301,796 - $337,198
-1,788 Reduced 42.21%
2,448 $426,000
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $708,640 - $809,076
4,236
4,236 $790,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ifrah Financial Services, Inc. Portfolio

Follow Ifrah Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ifrah Financial Services, Inc. with notifications on news.